FMTX - Forma Therapeutics Holdings Inc Ordinary Shares (Healthcare: Biotechnology) Projected Earnings Date: 2023-06-02    (Delayed quote data   )
Last
 		 Change
 ⇓ 0.00   (%)		 Volume
  0
Open
 		 High
 		 Low
 
8EMA (Daily)
 0.00		 40EMA (Daily)
 		 50EMA (Daily)
 		 STO (Daily)
 		 MACD Hist (Daily)
 
8EMA (Weekly)
 18.686		 40EMA (Weekly)
 14.13		 50EMA (Weekly)
 14.48		 STO (Weekly)
 97.708		 MACD Hist (Weekly)
 1.813
Company Profile
Forma Therapeutics Holdings Inc is a clinical-stage biopharmaceutical company. It is focused on the development and commercialization of novel therapeutics to transform the lives of patients with rare hematologic diseases and cancers. The firm's pipeline products are FT-4202, FT-7051, FT-8225, and others.
optionchance optionchance
⇒ Home | Chart and Research | Education | About Us  

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.

Questions or Comments: support@optionchance.com
Copyright © 2025 OptionChance.com